NIH R01 · 2025
Approximately 750,000 adults in the United States (US) have end-stage kidney disease (ESKD), where they require either dialysis or a kidney transplant in order to survive. Although in-center hemodialysis (HD) is the most common treatment for ESKD, it is associated with extremely high costs and poor health outcomes. Advances in communications technologies, combined with broad access to these technologies, have led many US policymakers and healthcare providers to champion telehealth as a way to improve access to care and to reduce costs in various healthcare settings, including the monitoring and treatment of patients with chronic disease. Until recently, regulatory barriers have effectively…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.